Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA-FDA Working Group To Develop Best Practices For Data Mining

Executive Summary

A Pharmaceutical Research & Manufacturers of America-FDA working group is looking at developing "best practices" for data mining techniques to identify potential safety signals

You may also be interested in...



FDA Moves Ahead With Adverse Event Data-Mining; “White Paper” Out Soon

An FDA-PhRMA working group is finalizing a "white paper" on data mining as a tool in postmarketing safety surveillance

FDA Moves Ahead With Adverse Event Data-Mining; “White Paper” Out Soon

An FDA-PhRMA working group is finalizing a "white paper" on data mining as a tool in postmarketing safety surveillance

FDA Adverse Event Data Mining Systems To Be Created By Lincoln Technologies

FDA's agreement with Boston-based Lincoln Technologies to create adverse event data mining technology is the second cooperative research and development agreement between the two

Related Content

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel